William G. Wright

Array ( [id] => 10031491 [patent_doc_number] => 09072791 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-07 [patent_title] => 'Photostabilized pharmaceutical compositions' [patent_app_type] => utility [patent_app_number] => 13/121852 [patent_app_country] => US [patent_app_date] => 2009-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12554 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 165 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13121852 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6048722 [patent_doc_number] => 20110207770 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-25 [patent_title] => 'PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A SECOND ACTIVE INGREDIENT' [patent_app_type] => utility [patent_app_number] => 13/058792 [patent_app_country] => US [patent_app_date] => 2009-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15754 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20110207770.pdf [firstpage_image] =>[orig_patent_app_number] => 13058792 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6113591 [patent_doc_number] => 20110190324 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'METHODS OF TREATING ATHEROSCLEROSIS' [patent_app_type] => utility [patent_app_number] => 12/997963 [patent_app_country] => US [patent_app_date] => 2009-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 19739 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20110190324.pdf [firstpage_image] =>[orig_patent_app_number] => 12997963 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6186611 [patent_doc_number] => 20110124670 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'Use of Pyrimidylaminobenzamide Derivatives for the Treatment of Fibrosis' [patent_app_type] => utility [patent_app_number] => 13/054011 [patent_app_country] => US [patent_app_date] => 2009-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5145 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20110124670.pdf [firstpage_image] =>[orig_patent_app_number] => 13054011 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9375878 [patent_doc_number] => 08680143 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-25 [patent_title] => 'Orally active curcuminoid compounds' [patent_app_type] => utility [patent_app_number] => 13/002588 [patent_app_country] => US [patent_app_date] => 2009-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7822 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13002588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7568051 [patent_doc_number] => 20110288114 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-24 [patent_title] => 'COMPOSITIONS FOR THE TREATMENT OF FIBROTIC DISEASES OR CONDITIONS' [patent_app_type] => utility [patent_app_number] => 13/001281 [patent_app_country] => US [patent_app_date] => 2009-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 8213 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0288/20110288114.pdf [firstpage_image] =>[orig_patent_app_number] => 13001281 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6003466 [patent_doc_number] => 20110118350 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'COMPOSITION FOR PREVENTING CARDIOVASCULAR EVENT IN HIGH-RISK PATIENT' [patent_app_type] => utility [patent_app_number] => 12/993715 [patent_app_country] => US [patent_app_date] => 2009-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8114 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20110118350.pdf [firstpage_image] =>[orig_patent_app_number] => 12993715 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10069593 [patent_doc_number] => 09107929 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-18 [patent_title] => 'Stable parenteral formulations of tigecycline' [patent_app_type] => utility [patent_app_number] => 12/434499 [patent_app_country] => US [patent_app_date] => 2009-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3625 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12434499 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5929855 [patent_doc_number] => 20110039814 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-17 [patent_title] => 'LIPID COMPOSITION' [patent_app_type] => utility [patent_app_number] => 12/989948 [patent_app_country] => US [patent_app_date] => 2009-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5632 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20110039814.pdf [firstpage_image] =>[orig_patent_app_number] => 12989948 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10521590 [patent_doc_number] => 09248082 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-02-02 [patent_title] => 'Anti-aging composition containing phloretin' [patent_app_type] => utility [patent_app_number] => 12/386224 [patent_app_country] => US [patent_app_date] => 2009-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6060 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 191 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12386224 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5972594 [patent_doc_number] => 20110152227 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'DEUTERIUM LABELLED DERIVATIVES OF 3-(2-HYDROXY-5-METHYPHENYL)-N,N-DIISOPROPYL-3-PHENYLPROPYLAMINE AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/937262 [patent_app_country] => US [patent_app_date] => 2009-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 16104 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20110152227.pdf [firstpage_image] =>[orig_patent_app_number] => 12937262 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8199671 [patent_doc_number] => 20120122990 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'OLEOYLETHANOLAMIDE BASED FUNCTIONAL MESOPHASES' [patent_app_type] => utility [patent_app_number] => 12/935819 [patent_app_country] => US [patent_app_date] => 2009-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3858 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20120122990.pdf [firstpage_image] =>[orig_patent_app_number] => 12935819 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6251701 [patent_doc_number] => 20100028299 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'Methods and compositions of treating a flaviviridae family viral infection' [patent_app_type] => utility [patent_app_number] => 12/383030 [patent_app_country] => US [patent_app_date] => 2009-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 42951 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20100028299.pdf [firstpage_image] =>[orig_patent_app_number] => 12383030 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6267190 [patent_doc_number] => 20100298338 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'METHOD OF OPTIMIZING THE TREATMENT OF PROLIFERATIVE DISEASES MEDIATED BY THE TYROSINE KINASE RECEPTOR KIT' [patent_app_type] => utility [patent_app_number] => 12/863627 [patent_app_country] => US [patent_app_date] => 2009-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2336 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20100298338.pdf [firstpage_image] =>[orig_patent_app_number] => 12863627 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6572564 [patent_doc_number] => 20100234675 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'COMPOSITION AND METHOD TO MODIFY SPERM FERTILITY AND FEMALE GENDER RATIO IN MAMMALS' [patent_app_type] => utility [patent_app_number] => 12/733927 [patent_app_country] => US [patent_app_date] => 2008-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4973 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20100234675.pdf [firstpage_image] =>[orig_patent_app_number] => 12733927 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6267620 [patent_doc_number] => 20100298388 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'SUBSTITUTED BENAMIDINES AS ANTIBACTERIAL AGENTS' [patent_app_type] => utility [patent_app_number] => 12/679334 [patent_app_country] => US [patent_app_date] => 2008-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9406 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20100298388.pdf [firstpage_image] =>[orig_patent_app_number] => 12679334 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6446834 [patent_doc_number] => 20100279984 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'PHARMACEUTICAL COMPOSITIONS CONTAINING BENFOTIAMINE AND ONE OR ONE MORE PHARMACEUTICALLY ACTIVE AGENTS FOR THE TREATMENT OF PAIN CONDITIONS OF NEUROPATHIC ORIGIN' [patent_app_type] => utility [patent_app_number] => 12/681424 [patent_app_country] => US [patent_app_date] => 2008-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7204 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0279/20100279984.pdf [firstpage_image] =>[orig_patent_app_number] => 12681424 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8211235 [patent_doc_number] => 20120129808 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-24 [patent_title] => 'BLOOD COAGULATION REACTION INHIBITOR' [patent_app_type] => utility [patent_app_number] => 12/737114 [patent_app_country] => US [patent_app_date] => 2008-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5546 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20120129808.pdf [firstpage_image] =>[orig_patent_app_number] => 12737114 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8228486 [patent_doc_number] => 20120142685 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-07 [patent_title] => 'ORGANIC COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/594728 [patent_app_country] => US [patent_app_date] => 2008-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 54804 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12594728 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5323013 [patent_doc_number] => 20090061003 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'CARRIERS FOR DRUG DELIVERY' [patent_app_type] => utility [patent_app_number] => 12/057628 [patent_app_country] => US [patent_app_date] => 2008-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5690 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20090061003.pdf [firstpage_image] =>[orig_patent_app_number] => 12057628 [rel_patent_id] =>[rel_patent_doc_number] =>)